MyClyns, a New Standard of Personal Protection, is Now Available in Canada

Union Springs Pharmaceutical launches the first non-alcohol antiseptic spray that can be used directly in the eyes, nose, mouth and open wounds.

Union, KY USA. (November 10, 2008) – Union Springs Pharmaceuticals, LLC, announced the revolutionary product MyClynsTM is now available in the Canadian market. MyClyns is currently sold to U.S. first responders and health care professionals who need to protect themselves from exposure to harmful pathogens. The product, a convenient pen-sized non-aerosol spray device, kills germs while at the same time being safe to use in the eyes, nose, mouth, and open wounds. Independent laboratory tests show that the solution in MyClyns kills >99.99% of MRSA, Hepatitis C, HIV-1, C-Diff, Anthrax, TB, and more than 60 other pathogens in many cases in as little as 15 seconds.

MyClyns is now available through select Canadian distributors including EMRN, Kudan Safety International, Sands Medical, and Vancouver Surgical. More information on MyClyns and a listing of distributors can be found at www.myclyns.ca.

“MyClyns has had an extremely positive response from EMS, fire, police, corrections, and military professionals in the U.S.,” said Joel Ivers, President of Union Springs Pharmaceuticals. “We have had a very strong interest from Canadian agencies and we are excited to now offer MyClyns in Canada,” he added.

The versatility of MyClyns has been demonstrated by the more than 1,000 municipal organizations and government agencies that have purchased the product this year. Situations where MyClyns has been used to treat exposures include:

Police officers, when a suspect is resisting arrest, struggling, or spitting.
Corrections officers, when inmates who often have drug, alcohol, or mental health issues become combative, and even spit or throw feces.
Fire and EMS/EMT personnel when responding to emergency calls that range from treating elderly victims with compromised immune systems to helping traffic accident victims that are critically injured.
Military personnel when exposed to unusual germs in foreign countries, or as protection from hazardous “biological” agents.

MyClyns contains a fast-acting solution with virucidal and bactericidal action that is safe to use on the eyes, ears, nose, mouth and open wounds. The MyClyns convenient pen-like design allows first responders to protect themselves immediately after exposure to harmful pathogens even while still caring for those in emergency situations.

The contents of this release apply only to products available in Canada.

About MyClynsTM
MyClyns™ is the only germ-killing spray for the eyes, ears, nose, mouth, and open wounds. Independent laboratory tests show that the solution in MyClyns kills >99.99% of MRSA, Hepatitis C, and HIV-1 and more than 60 other pathogens. MyClyns protects personnel immediately after exposure to harmful pathogens while allowing them to continue to attend to the situation at hand. Visit the MyClyns website at www.myclyns.ca for more information.

About Union Springs Pharmaceuticals, LLC
Union Springs Pharmaceuticals, LLC (USP) specializes in providing innovative products for the consumer and healthcare markets. USP develops, licenses, acquires, and commercializes innovative products and technologies that satisfy the unmet needs of healthcare professionals and consumers. Union Springs Pharmaceuticals can be found on the Internet at www.uspharma.com